Expert Ratings For GE HealthCare Techs
Portfolio Pulse from Benzinga Insights
Over the past three months, 7 analysts have evaluated GE HealthCare Techs (NASDAQ:GEHC), with a mix of bullish and neutral ratings. The average 12-month price target has increased by 7.1% to $100.14. Analysts have adjusted their ratings and price targets in response to market conditions and company performance.
May 30, 2024 | 12:01 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Analysts have mixed views on GE HealthCare Techs, with a recent increase in the average 12-month price target by 7.1% to $100.14. The company faces challenges in revenue growth and profitability but shows strong return on equity.
The increase in the average price target by 7.1% indicates a positive outlook from analysts despite mixed ratings. The company's strong return on equity and recent analyst upgrades suggest potential short-term gains.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100